New data demonstrate clinical validation of novel prostate cancer test

by

OncoAssure Ltd, an Irish medical diagnostic company, announced the publication of new data in the journal BJUI Compass that demonstrate the clinical validation of OncoAssure Prostate, a novel biopsy test that provides improved estimation of a patient’s risk of prostate cancer recurrence and allows for optimal treatment selection.

Leave A Comment

Your email address will not be published. Required fields are marked *